Reviewed clinical summary · Source-linked · Educational use only

Low-Carb High-PUFA vs Healthy Nordic Diet for Liver Fat in Type 2 Diabetes (NAFLDiet)

Hormone Insight visual abstract summarising NAFLDiet and liver fat in type 2 diabetes or prediabetes.
Visual abstract for NAFLDiet and liver fat.

Clinical Bottom Line

The NAFLDiet trial finds both a low-carb high-PUFA diet and a healthy Nordic diet reduce liver fat versus usual care, but only the Nordic diet also improves weight, HbA1c, triglycerides, and inflammation. PICO summary and commentary.

Summary: In a 12-month trial in type 2 diabetes or prediabetes, both a low-carbohydrate high-polyunsaturated-fat diet and a healthy Nordic diet reduced liver fat similarly versus usual care, but only the Nordic diet further improved weight, HbA1c, triglycerides, inflammation, and liver enzymes.

PICO Summary

ElementDetail
Population150 adults with prediabetes or type 2 diabetes (55%); three-arm ad libitum randomised trial over 12 months, Sweden (NAFLDiet).
InterventionAn anti-lipogenic low-carbohydrate high-polyunsaturated-fat diet (LCPUFA, n=54) or a low-fat healthy Nordic diet rich in whole grains (HND, n=51).
ComparisonUsual care (n=43).
OutcomeLiver fat fell similarly with both diets versus usual care (LCPUFA -1.46%; HND -1.76%), with no difference between the diets. Both reduced LDL-cholesterol similarly versus usual care. However, only the Nordic diet further reduced body weight, HbA1c, triglycerides, inflammation, and liver enzymes; the LCPUFA diet was no better than usual care for weight or HbA1c.
RCT Nat Commun · 2025

NAFLDiet: diet and liver fat in type 2 diabetes

RCT · type 2 diabetes / prediabetes · 12 months

Trial design
150 adults, T2D/prediabetes Enrolled & assessed RANDOMISED 1:1:1 Healthy Nordic diet Whole grains, fish, oils n = 51 Usual care Standard advice n = 43 Change in liver fat (%) vs usual care
Between-group effect (95% CI)
0 (no difference) -3.5 1 Nordic diet vs usual care-1.76 ✓Low-carb high-PUFA vs usual care-1.46 ✓ Liver fat change (% points) · ✓ = significant
HND liver fat
-1.76%
vs usual care
LCPUFA liver fat
-1.46%
vs usual care
Weight & HbA1c
HND only
LCPUFA = usual care
Triglycerides, CRP
HND only
liver enzymes too
⬡ Bottom Line

Both diets cut liver fat similarly versus usual care, but only the healthy Nordic diet also improved body weight, HbA1c, triglycerides, inflammation, and liver enzymes.

Expert Commentary

This is a strong year-long trial with a clinically meaningful primary outcome, liver fat measured rigorously, and its nuanced result deserves accurate reporting rather than a blanket both-diets-worked summary. On the primary endpoint the two diets were equivalent and both beat usual care, lowering liver fat to a similar degree, and both lowered LDL similarly, with the polyunsaturated-fat emphasis sensibly avoiding the saturated-fat concerns of traditional low-carbohydrate approaches. But the secondary outcomes separate them clearly: only the Nordic diet improved body weight, HbA1c, triglycerides, inflammation, and liver enzymes, while the low-carbohydrate high-PUFA diet was no better than usual care for weight or glycaemia. So for the broader cardiometabolic picture the Nordic pattern was superior, even without intentional energy restriction. Limitations include the absence of liver histology, so fibrosis effects are unknown, varying adherence as in all diet trials, and a Swedish population and food culture. Can I use this with my patients? Yes, with a steer. Both diets reduce liver fat and are reasonable structured options over generic advice, but where I want simultaneous benefit on weight and glycaemia I would favour a Nordic-style or comparable whole-grain, fish, and plant-oil pattern, ideally with dietitian support, rather than assuming the low-carbohydrate route delivers equal metabolic gains.

References

Fridén M, Rosqvist F, Kullberg J, et al. Effects of an anti-lipogenic low-carbohydrate high polyunsaturated fat diet or a healthy Nordic diet versus usual care on liver fat and cardiometabolic disorders in type 2 diabetes or prediabetes: a randomized controlled trial (NAFLDiet). Nat Commun. 2025;16(1):11130. doi:10.1038/s41467-025-65613-2

Educational use: Hormone Insight is intended for healthcare professionals and learners. Interpret each summary alongside the primary source, local guidance, and patient-specific clinical judgement.

Subscribe now

Welcome to Hormone Insight. Our mission is to support clinical decision-making with accessible, evidence-based insights from recent studies and trials.

© 2024-2026 Hormone Insight. All rights reserved.